These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8143931)

  • 1. All-trans-retinoic acid and hexamethylene bisacetamide (HMBA) regulate TGF-alpha and Hst-1/kFGF expression in differentiation sensitive but not in resistant human teratocarcinomas.
    Miller WH; Maerz WJ; Kurie J; Moy D; Baselga J; Lucas DA; Grippo JF; Masui H; Dmitrovsky E
    Differentiation; 1994 Jan; 55(2):145-52. PubMed ID: 8143931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.
    Baselga J; Maerz WJ; Moy D; Miller WH; Castro L; Reuter VE; Yao TJ; Masui H; Dmitrovsky E
    Oncogene; 1993 Dec; 8(12):3257-63. PubMed ID: 8247529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
    Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
    Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
    Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
    Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
    Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
    Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.
    Moasser MM; DeBlasio A; Dmitrovsky E
    Oncogene; 1994 Mar; 9(3):833-40. PubMed ID: 8108126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-cis and all-trans retinoic acid induce a similar phenotype in human teratocarcinoma cells.
    Kurie JM; Buck J; Eppinger TM; Moy D; Dmitrovsky E
    Differentiation; 1993 Sep; 54(2):123-9. PubMed ID: 8243889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
    Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
    Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid causes a decline in TGF-alpha expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line.
    Dmitrovsky E; Moy D; Miller WH; Li A; Masui H
    Oncogene Res; 1990; 5(3):233-9. PubMed ID: 2320376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid stimulates protein kinase A-associated G proteins during human teratocarcinoma differentiation.
    Kurie JM; Allopenna J; Dmitrovsky E
    Biochim Biophys Acta; 1994 May; 1222(1):88-94. PubMed ID: 8186270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between retinoic acid and phorbol esters enhances human teratocarcinoma differentiation.
    Kurie JM; Brown P; Salk E; Scheinberg D; Birrer M; Deutsch P; Dmitrovsky E
    Differentiation; 1993 Sep; 54(2):115-22. PubMed ID: 8243888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
    Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
    Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid stimulates the protein kinase C pathway before activation of its beta-nuclear receptor during human teratocarcinoma differentiation.
    Kurie JM; Younes A; Miller WH; Burchert M; Chiu CF; Kolesnick R; Dmitrovsky E
    Biochim Biophys Acta; 1993 Nov; 1179(2):203-7. PubMed ID: 8218362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
    Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
    Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of connexin43 expression and dye-coupling during neuronal differentiation of human NTera2/clone D1 cells.
    Bani-Yaghoub M; Bechberger JF; Naus CC
    J Neurosci Res; 1997 Jul; 49(1):19-31. PubMed ID: 9211986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM; Infante D; Winawer S; Friedman E
    Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays.
    Hassan HT; Veit A; Maurer HR
    J Cancer Res Clin Oncol; 1991; 117(3):227-31. PubMed ID: 1709642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.
    Curtin JC; Dragnev KH; Sekula D; Christie AJ; Dmitrovsky E; Spinella MJ
    Oncogene; 2001 May; 20(20):2559-69. PubMed ID: 11420666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation.
    Baldassarre G; Barone MV; Belletti B; Sandomenico C; Bruni P; Spiezia S; Boccia A; Vento MT; Romano A; Pepe S; Fusco A; Viglietto G
    Oncogene; 1999 Nov; 18(46):6241-51. PubMed ID: 10597222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.